Human Equilibrative Nucleoside Transporter 1: Novel Biomarker and Prognostic Indicator for Patients with Gemcitabine-Treated Pancreatic Cancer.

Jianchun XiaoFangyu ZhaoWen-Hao LuoGang YangYicheng WangJiangdong QiuYueze LiuLei YouLianfang ZhengTaiping Zhang

Published in: Cancer management and research (2024)

PC patients with high hENT1 expression have a better survival outcomes when receiving Gemcitabine. hENT1 expression can be a great prognostic indicator for PC patients to receive Gemcitabine treatment.

Keyphrases

poor prognosis
end stage renal disease
newly diagnosed
locally advanced
endothelial cells
chronic kidney disease
ejection fraction
prognostic factors
binding protein
squamous cell carcinoma
patient reported outcomes
induced pluripotent stem cells
smoking cessation